These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 26266346)

  • 1. Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study.
    Cavagna L; Nuño L; Scirè CA; Govoni M; Longo FJL; Franceschini F; Neri R; Castañeda S; Giraldo WAS; Caporali R; Iannone F; Fusaro E; Paolazzi G; Pellerito R; Schwarting A; Saketkoo LA; Ortego-Centeno N; Quartuccio L; Bartoloni E; Specker C; Murcia TP; La Corte R; Furini F; Foschi V; Corral JB; Airò P; Cavazzana I; Martínez-Barrio J; Hinojosa M; Giannini M; Barsotti S; Menke J; Triantafyllias K; Vitetta R; Russo A; Bajocchi G; Bravi E; Barausse G; Bortolotti R; Selmi C; Parisi S; Montecucco C; González-Gay MA;
    Medicine (Baltimore); 2015 Aug; 94(32):e1144. PubMed ID: 26266346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group.
    Cavagna L; Nuño L; Scirè CA; Govoni M; Longo FJ; Franceschini F; Neri R; Castañeda S; Sifuentes Giraldo WA; Caporali R; Iannone F; Fusaro E; Paolazzi G; Pellerito R; Schwarting A; Saketkoo LA; Ortego-Centeno N; Quartuccio L; Bartoloni E; Specker C; Pina Murcia T; La Corte R; Furini F; Foschi V; Bachiller Corral J; Airò P; Cavazzana I; Martínez-Barrio J; Hinojosa M; Giannini M; Barsotti S; Menke J; Triantafyllias K; Vitetta R; Russo A; Bogliolo L; Bajocchi G; Bravi E; Barausse G; Bortolotti R; Selmi C; Parisi S; Salaffi F; Montecucco C; González-Gay MA;
    Clin Rev Allergy Immunol; 2017 Feb; 52(1):71-80. PubMed ID: 26782036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study.
    Bartoloni E; Gonzalez-Gay MA; Scirè C; Castaneda S; Gerli R; Lopez-Longo FJ; Martinez-Barrio J; Govoni M; Furini F; Pina T; Iannone F; Giannini M; Nuño L; Quartuccio L; Ortego-Centeno N; Alunno A; Specker C; Montecucco C; Triantafyllias K; Balduzzi S; Sifuentes-Giraldo WA; Paolazzi G; Bravi E; Schwarting A; Pellerito R; Russo A; Selmi C; Saketkoo LA; Fusaro E; Parisi S; Pipitone N; Franceschini F; Cavazzana I; Neri R; Barsotti S; Codullo V; Cavagna L
    Autoimmun Rev; 2017 Mar; 16(3):253-257. PubMed ID: 28147261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China.
    Zhan X; Yan W; Wang Y; Li Q; Shi X; Gao Y; Ye Q
    BMC Pulm Med; 2021 Feb; 21(1):57. PubMed ID: 33579248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical spectrum of anti-Jo-1-associated disease.
    Monti S; Montecucco C; Cavagna L
    Curr Opin Rheumatol; 2017 Nov; 29(6):612-617. PubMed ID: 28796005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the clinical features of antisynthetase syndrome: a retrospective cohort study in China.
    Wang R; Zhao Y; Qi F; Wu X; Wang Y; Xu Y; Wu Y; Zhang N; Hou H; Sun W; Li X; Wei W
    Clin Rheumatol; 2023 Mar; 42(3):703-709. PubMed ID: 36308573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical manifestations and long-term outcome of anti-Jo1 antisynthetase patients in a large cohort of Spanish patients from the GEAS-IIM group.
    Trallero-Araguás E; Grau-Junyent JM; Labirua-Iturburu A; García-Hernández FJ; Monteagudo-Jiménez M; Fraile-Rodriguez G; Les-Bujanda I; Rodriguez-Carballeira M; Sáez-Comet L; Selva-O'Callaghan A;
    Semin Arthritis Rheum; 2016 Oct; 46(2):225-231. PubMed ID: 27139168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing of onset affects arthritis presentation pattern in antisyntethase syndrome.
    González-Gay MA; Montecucco C; Selva-O'Callaghan A; Trallero-Araguas E; Molberg O; Andersson H; Rojas-Serrano J; Perez-Roman DI; Bauhammer J; Fiehn C; Neri R; Barsotti S; Lorenz HM; Doria A; Ghirardello A; Iannone F; Giannini M; Franceschini F; Cavazzana I; Triantafyllias K; Benucci M; Infantino M; Manfredi M; Conti F; Schwarting A; Sebastiani G; Iuliano A; Emmi G; Silvestri E; Govoni M; Scirè CA; Furini F; Lopez-Longo FJ; Martínez-Barrio J; Sebastiani M; Manfredi A; Bachiller-Corral J; Sifuentes Giraldo WA; Cimmino MA; Cosso C; Belotti Masserini A; Cagnotto G; Codullo V; Romano M; Paolazzi G; Pellerito R; Saketkoo LA; Ortego-Centeno N; Quartuccio L; Batticciotto A; Bartoloni Bocci E; Gerli R; Specker C; Bravi E; Selmi C; Parisi S; Salaffi F; Meloni F; Marchioni E; Pesci A; Dei G; Confalonieri M; Tomietto P; Nuno L; Bonella F; Pipitone N; Mera-Valera A; Perez-Gomez N; Gerzeli S; Lopez-Mejias R; Matos-Costa CJ; Pereira da Silva JA; Cifrian J; Alpini C; Olivieri I; Blázquez Cañamero MÁ; Rodriguez Cambrón AB; Castañeda S; Cavagna L;
    Clin Exp Rheumatol; 2018; 36(1):44-49. PubMed ID: 28770709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of MUC5B gene on antisynthetase syndrome.
    López-Mejías R; Remuzgo-Martínez S; Genre F; Pulito-Cueto V; Rozas SMF; Llorca J; Fernández DI; Cuesta VMM; Ortego-Centeno N; Gómez NP; Mera-Varela A; Martínez-Barrio J; López-Longo FJ; Mijares V; Lera-Gómez L; Usetti MP; Laporta R; Pérez V; Gafas AP; González MAA; Calvo-Alén J; Romero-Bueno F; Sanchez-Pernaute O; Nuno L; Bonilla G; Balsa A; Hernández-González F; Grafia I; Prieto-González S; Narvaez J; Trallero-Araguas E; Selva-O'Callaghan A; Gualillo O; Castañeda S; Cavagna L; Cifrian JM; González-Gay MA
    Sci Rep; 2020 Jan; 10(1):1415. PubMed ID: 31996780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Ro52 antibodies positivity in antisynthetase syndrome: a single centre cohort study.
    Bozzalla-Cassione E; Zanframundo G; Biglia A; Bellis E; Bozzini S; Codullo V; Vertui V; Alpini C; Valentini A; Preda L; Montecucco C; Meloni F; Cavagna L
    Clin Exp Rheumatol; 2022 May; 40 Suppl 134(5):27-31. PubMed ID: 35349417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and prognostic associations of anti-Jo-1 antibody levels in patients with antisynthetase syndrome.
    Yang H; Chen Q; Sun C; Jin Q; Zhang L; Liu Q; Peng Q; Wang G; Lu X
    Respir Res; 2024 May; 25(1):222. PubMed ID: 38811943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course.
    Cavagna L; Trallero-Araguás E; Meloni F; Cavazzana I; Rojas-Serrano J; Feist E; Zanframundo G; Morandi V; Meyer A; Pereira da Silva JA; Matos Costa CJ; Molberg O; Andersson H; Codullo V; Mosca M; Barsotti S; Neri R; Scirè C; Govoni M; Furini F; Lopez-Longo FJ; Martinez-Barrio J; Schneider U; Lorenz HM; Doria A; Ghirardello A; Ortego-Centeno N; Confalonieri M; Tomietto P; Pipitone N; Rodriguez Cambron AB; Blázquez Cañamero MÁ; Voll RE; Wendel S; Scarpato S; Maurier F; Limonta M; Colombelli P; Giannini M; Geny B; Arrigoni E; Bravi E; Migliorini P; Mathieu A; Piga M; Drott U; Delbrueck C; Bauhammer J; Cagnotto G; Vancheri C; Sambataro G; De Langhe E; Sainaghi PP; Monti C; Gigli Berzolari F; Romano M; Bonella F; Specker C; Schwarting A; Villa Blanco I; Selmi C; Ceribelli A; Nuno L; Mera-Varela A; Perez Gomez N; Fusaro E; Parisi S; Sinigaglia L; Del Papa N; Benucci M; Cimmino MA; Riccieri V; Conti F; Sebastiani GD; Iuliano A; Emmi G; Cammelli D; Sebastiani M; Manfredi A; Bachiller-Corral J; Sifuentes Giraldo WA; Paolazzi G; Saketkoo LA; Giorgi R; Salaffi F; Cifrian J; Caporali R; Locatelli F; Marchioni E; Pesci A; Dei G; Pozzi MR; Claudia L; Distler J; Knitza J; Schett G; Iannone F; Fornaro M; Franceschini F; Quartuccio L; Gerli R; Bartoloni E; Bellando Randone S; Zampogna G; Gonzalez Perez MI; Mejia M; Vicente E; Triantafyllias K; Lopez-Mejias R; Matucci-Cerinic M; Selva-O'Callaghan A; Castañeda S; Montecucco C; Gonzalez-Gay MA
    J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31752231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Jo-1 Syndrome Often Misdiagnosed as Rheumatoid Arthritis (for Many Years): A Single-Center Experience.
    Kumar RR; Jha S; Dhooria A; Naidu GSRSNK; Minz RW; Kumar S; Sharma SK; Sharma A; Jain S; Dhir V
    J Clin Rheumatol; 2021 Jun; 27(4):150-155. PubMed ID: 31895110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interstitial lung disease in anti-Jo-1 patients with antisynthetase syndrome.
    Marie I; Josse S; Hatron PY; Dominique S; Hachulla E; Janvresse A; Cherin P; Mouthon L; Vittecoq O; Menard JF; Jouen F
    Arthritis Care Res (Hoboken); 2013 May; 65(5):800-8. PubMed ID: 23203765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characterisation of a multicentre nationwide cohort of patients with antisynthetase syndrome.
    Martins P; Dourado E; Melo AT; Samões B; Sousa M; Freitas R; Lourenço MH; Fernandes B; Costa E; Parente H; Martins F; Fonseca JE; Cordeiro I; Romão VC; Khmelinskii N; Campanilho-Marques R
    ARP Rheumatol; 2022 Nov; 1(ARP Rheumatology, nº3 2022):190-196. PubMed ID: 35891592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and outcomes of interstitial lung disease in anti-Jo-1 positive antisynthetase syndrome.
    Zamora AC; Hoskote SS; Abascal-Bolado B; White D; Cox CW; Ryu JH; Moua T
    Respir Med; 2016 Sep; 118():39-45. PubMed ID: 27578469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myositis-related interstitial lung disease and antisynthetase syndrome.
    Solomon J; Swigris JJ; Brown KK
    J Bras Pneumol; 2011; 37(1):100-9. PubMed ID: 21390438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literature.
    Labirua-Iturburu A; Selva-O'Callaghan A; Vincze M; Dankó K; Vencovsky J; Fisher B; Charles P; Dastmalchi M; Lundberg IE
    Medicine (Baltimore); 2012 Jul; 91(4):206-211. PubMed ID: 22732951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease.
    Richards TJ; Eggebeen A; Gibson K; Yousem S; Fuhrman C; Gochuico BR; Fertig N; Oddis CV; Kaminski N; Rosas IO; Ascherman DP
    Arthritis Rheum; 2009 Jul; 60(7):2183-92. PubMed ID: 19565490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicoserological features of antisynthetase syndrome (ASyS)-associated interstitial lung disease presenting to respiratory services: comparison with idiopathic pulmonary fibrosis and ASyS diagnosed in rheumatology services.
    Barratt SL; Adamali HH; Cotton C; Mulhearn B; Iftikhar H; Pauling JD; Spencer L; Adamali HI; Gunawardena H
    BMJ Open Respir Res; 2021 Jan; 8(1):. PubMed ID: 33419741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.